Teriparatide (TPT), the recombinant human 1–34 parathyroid hormone, is a bone anabolic agent that is approved for the treatment of postmenopausal osteoporosis in women, hypogonadal osteoporosis in men, and glucocorticoid induced osteoporosis. Here, PTH is linked to osteoporosis.